Merck Cholesterol Drug Vytorin in Study - Health Blog - WSJ
Links shared publicly online about this topic.
- 1,605total visits
Merck Cholesterol Drug Vytorin in Study - Health Blog - WSJ
View full resource at blogs.wsj.com
Tags: Cholesterol, Cholesterol Medication, Drug, Vytorin, Merck & Co.
Most Recently Shared on November 13, 2009 at 2:10 pm By:
The Next Vytorin Study: Why Is Everybody So Worked Up? http://bit.ly/4qcoiP
Sage Advice On Vytorin - Forbes
forbes.com — “So what is the bottom line on the continuing kerfluffle over the cholesterol drugs Zetia and Vytorin, sold by Merck? The basic problem is this: What should patients and doctors do when insufficient data is collected on a new medicine? Merck has lots of studies showing that Zetia lowers cholesterol, but [...]” View full resource at forbes.com
Most Recently Shared on March 29, 2012 at 12:10 pm By:
Since it came up today, here's what I still think is the bottom line on Zetia. http://t.co/3tv3VyCW
Merck's Vytorin cuts heart attack risk in kidney patients
health.yahoo.net — “Kidney disease patients treated with Merck & Co Inc's cholesterol-lowering drug Vytorin were about 16 percent less likely to have a heart attack or other cardiovascular problem than patients given a dummy pill, according to a new study.” View full resource at health.yahoo.net
Most Recently Shared on November 20, 2010 at 7:20 pm By:
Jane Anderson Healthy Eating Advisor
Merck's Vytorin cuts heart attack risk in kidney patients http://bit.ly/clW8Q7
Merck's Vytorin cuts heart attack risk in kidney patients
health.yahoo.net — “Kidney disease patients treated with Merck & Co Inc's cholesterol-lowering drug Vytorin were about 16 percent less likely to have a heart attack or other cardiovascular problem than patients given a dummy pill, according to a new study.” View full resource at health.yahoo.net
Most Recently Shared on November 20, 2010 at 7:05 pm By:
Jennifer Ann Grisso Nurse and Active Health Library
Merck's Vytorin cuts heart attack risk in kidney patients: Kidney disease patients treated with Merck & Co Inc's... http://bit.ly/cvZ6oJ
Study raises new questions about Merck pill Zetia
jerebeasleyreport.com — “A new study has raised new concerns about Zetia and Vytorin - drugs that are still taken by millions of Americans to lower cholesterol, despite questions raised” View full resource at jerebeasleyreport.com
Most Recently Shared on December 17, 2009 at 12:02 am By:
Tammi Jacobs Health Professional
Study raises new questions about Merck pill Zetia http://bit.ly/68deZo
Advertisement
